These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6218653)

  • 21. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells.
    Yasukawa M; Shiroguchi T; Inatsuki A; Kobayashi Y
    Blood; 1988 Jul; 72(1):102-8. PubMed ID: 2455565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plaque-forming cells in man. III. Generation of plaque-forming cells in allogeneic in vitro cultures of HLA-D/DR-incompatible B and T lymphocytes.
    Tauris P; Johnsen HE; Christiansen SE; Kissmeyer-Nielsen F
    Scand J Immunol; 1984 May; 19(5):419-24. PubMed ID: 6233695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture.
    Suciu-Foca N; Rohowsky C; Kung P; King DW
    J Exp Med; 1982 Jul; 156(1):283-8. PubMed ID: 6177823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of HLA-DR alloantigens on acute lymphoblastic leukemia lymphoblasts.
    Orgad S; Yunis EJ; Zaizov R; Ramot B; Altshuler R; Gazit E
    Hum Immunol; 1984 Feb; 9(2):67-74. PubMed ID: 6421779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of HLA-D(DR)4 detected by primary and secondary mixed-lymphocyte-culture reactions and by individual HLA-DR4 antisera.
    Petzl ML; Scholz S; Albert ED
    Immunobiology; 1982 Aug; 162(3):265-76. PubMed ID: 6215336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HLA-DR antigens with the autologous mixed lymphocyte reaction.
    Davey FR; Kurec AS; Dock NL; Hubbell C; Falen SW
    Tissue Antigens; 1984 Aug; 24(2):98-106. PubMed ID: 6238447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow.
    Pizzolo G; Ambrosetti A; Semenzato G; Rossetti G; Morittu L; Chilosi M; Agostini C; Perona G
    Blut; 1984 Aug; 49(2):69-73. PubMed ID: 6331866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.
    Knowles DM
    Hum Pathol; 1986 Jan; 17(1):14-33. PubMed ID: 3002948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens.
    Dazzi F; D'Andrea E; Biasi G; De Silvestro G; Gaidano G; Schena M; Tison T; Vianello F; Girolami A; Caligaris-Cappio F
    Clin Immunol Immunopathol; 1995 Apr; 75(1):26-32. PubMed ID: 7882591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of anomalous HLA reactivity in the typing of neoplastic lymphoreticular cells.
    Huntington SJ; Davey FR
    Prog Clin Biol Res; 1977; 16():91-102. PubMed ID: 71745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
    Shawler DL; Glassy MC; Wormsley SB; Royston I
    J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures.
    Breuning MH; Breur BS; Engelsma MY; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro function of a T-cell chronic lymphocytic leukemia with suppressor cell phenotype.
    Crosier PS
    Aust N Z J Med; 1986 Jun; 16(3):389-92. PubMed ID: 2946284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of T-lymphoblast-encoded HLA-DR, MT, and SB antigens on human T-B lymphoblast hybrids.
    Howell DN; Hartzman RJ; Cresswell P
    Hum Immunol; 1983 Oct; 8(2):167-75. PubMed ID: 6417070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-DR beta III and HLA-DP induce comparable proliferation in primary mixed lymphocyte culture.
    Schroeijers WE; de Koster HS; van Rood JJ; Termijtelen A
    Tissue Antigens; 1988 Sep; 32(3):145-9. PubMed ID: 2464203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.